Status:
COMPLETED
SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Diabetes Mellitus in Pregnancy
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Diabetes during pregnancy is a challenging clinical situation requiring substantial patient engagement. The investigators have developed a novel early-phase tool, called SweetMama, that incorporates e...
Detailed Description
In prior work, the investigators created a text messaging curriculum that was well-received by patients for diabetes-related education and support during pregnancy. The team has now drawn upon these e...
Eligibility Criteria
Inclusion
- Age 18 and older
- Gestational diabetes mellitus or type 2 diabetes mellitus
- English-speaking
- Gestational age
- Focus groups: Confirmed intrauterine pregnancy at least 8 weeks' gestational age or postpartum until 12 weeks after delivery
- Individual testing: Confirmed intrauterine pregnancy prior to 30 weeks' gestational age
- Pilot trial: Confirmed intrauterine pregnancy prior to 30 weeks' gestational age
- Low income, defined as use of publicly-supported insurance for prenatal care or household income \<200% of poverty line for family size
- Access to a mobile smartphone ( for longitudinal testing phase)
Exclusion
- Failure to meet the inclusion criteria above
- Non-viable pregnancy
Key Trial Info
Start Date :
August 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 9 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03240874
Start Date
August 2 2017
End Date
April 9 2021
Last Update
August 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611